Form preview

Get the free Consent for Administration of Radioactive Yttrium-90 Zevalin Therapy for Non-Hodgkin...

Get Form
This document serves as a consent form for patients undergoing treatment with Radioactive Yttrium-90 Zevalin for Non-Hodgkin’s Lymphoma, detailing the procedure, risks, benefits, and alternatives.
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign consent for administration of

Edit
Edit your consent for administration of form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your consent for administration of form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing consent for administration of online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Follow the steps down below to take advantage of the professional PDF editor:
1
Register the account. Begin by clicking Start Free Trial and create a profile if you are a new user.
2
Simply add a document. Select Add New from your Dashboard and import a file into the system by uploading it from your device or importing it via the cloud, online, or internal mail. Then click Begin editing.
3
Edit consent for administration of. Add and change text, add new objects, move pages, add watermarks and page numbers, and more. Then click Done when you're done editing and go to the Documents tab to merge or split the file. If you want to lock or unlock the file, click the lock or unlock button.
4
Save your file. Choose it from the list of records. Then, shift the pointer to the right toolbar and select one of the several exporting methods: save it in multiple formats, download it as a PDF, email it, or save it to the cloud.
pdfFiller makes working with documents easier than you could ever imagine. Create an account to find out for yourself how it works!

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out consent for administration of

Illustration

How to fill out Consent for Administration of Radioactive Yttrium-90 Zevalin Therapy for Non-Hodgkin’s Lymphoma

01
Begin by downloading or obtaining the Consent form for Administration of Radioactive Yttrium-90 Zevalin Therapy.
02
Read the introduction section carefully to understand the purpose of the therapy.
03
Fill in your personal information such as name, date of birth, and contact details in the designated fields.
04
Review the information about the therapy, including potential risks and benefits, which should be outlined in the document.
05
Indicate whether you have discussed the therapy with your healthcare provider by checking the provided box or marking the appropriate section.
06
Write in any questions or concerns you may have about the therapy in the space provided.
07
Signature: Sign and date the form to indicate your consent for the treatment.
08
Make a copy of the signed consent for your records before submitting it to your healthcare provider.

Who needs Consent for Administration of Radioactive Yttrium-90 Zevalin Therapy for Non-Hodgkin’s Lymphoma?

01
Patients diagnosed with Non-Hodgkin’s Lymphoma who are being considered for Radioactive Yttrium-90 Zevalin Therapy.
02
Individuals who consent to the administration of this specific therapy as part of their treatment plan.
03
Patients who have been informed by their healthcare provider about the therapy and its implications.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.0
Satisfied
33 Votes

People Also Ask about

Approval Date: 10/25/02.
In September 2014, a sustained release formulation of the drug was approved for marketing in the United States under the brand name Contrave. The combination was subsequently approved in the European Union in the spring of 2015, where it is sold under the name Mysimba.
The cost for Y-90 Zevalin (3.2 mg/2 mL) intravenous kit is around $71,325 for a supply of 1 kits, depending on the pharmacy you visit.
Zevalin, the first conjugated antibody for the treatment of non-hodgkin's lymphoma (NHL) (and the first radioimmunotherapeutic for cancer) was approved by the US FDA on 19 February 2002 (approval is pending in the EEC). Zevalin (90Yttrium ibritumomab tiuxetan) has been in clinical trials since 1992.
On January 16, 2025, the Food and Drug Administration granted traditional approval to acalabrutinib (Calquence, AstraZeneca) with bendamustine and rituximab for adults with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT).
Radiation might be used to treat non-Hodgkin lymphoma (NHL) in some different situations: It can be used as the main treatment for some types of NHL if they are found early (stage I or II). For more advanced lymphomas and for some lymphomas that are more aggressive, radiation is sometimes used along with chemotherapy.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Consent for Administration of Radioactive Yttrium-90 Zevalin Therapy is a legal document that allows a patient diagnosed with Non-Hodgkin’s Lymphoma to undergo treatment with Yttrium-90 labeled Zevalin, which is a form of targeted radiation therapy used to treat this type of cancer.
The patient diagnosed with Non-Hodgkin’s Lymphoma, or their legal guardian or representative, is required to file the consent form prior to receiving the Yttrium-90 Zevalin therapy.
To fill out the consent form, the patient or guardian should provide their personal information, understand the risks and benefits of the therapy, confirm that they have had an opportunity to ask questions, and sign the form to give consent for the treatment.
The purpose of the consent form is to ensure that the patient is fully informed about the Yttrium-90 Zevalin therapy, its potential side effects, and the expected outcomes, thereby allowing them to make an informed decision about their treatment.
The consent form must report patient identifying details, the nature of the therapy, potential risks and benefits, alternative treatments available, and a signature indicating voluntary consent.
Fill out your consent for administration of online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.